| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80061 |
Lipid panel |
356 |
237 |
$0.00 |
| 84439 |
|
17 |
17 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
126 |
102 |
$0.00 |
| 83540 |
|
83 |
69 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
637 |
366 |
$0.00 |
| 84466 |
|
81 |
67 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
511 |
370 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
293 |
200 |
$0.00 |
| 85027 |
|
129 |
94 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
72 |
51 |
$0.00 |
| 82728 |
|
147 |
113 |
$0.00 |
| 81001 |
|
26 |
24 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
435 |
356 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
204 |
143 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
302 |
217 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12 |
12 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
126 |
102 |
$0.00 |
| 87081 |
|
546 |
354 |
$0.00 |
| 87088 |
|
169 |
114 |
$0.00 |
| 87077 |
|
72 |
60 |
$0.00 |
| 82607 |
|
156 |
108 |
$0.00 |
| 86592 |
|
42 |
28 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
515 |
361 |
$0.00 |
| 80050 |
General health panel |
36 |
13 |
$0.00 |